Search for Abstracts Find by Title, Author or Description Year Abstracts - 2025 - 2024 - 2023 - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-NuclearMedicine-InterventionalRadiology-Imaging Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology O OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first NANETS 2024 Symposium Abstract C 1 (1) Published in 2024 Download [B10] Forsythe - Development of GEP-NEN Patient Derived Organoids for Long Term Culture and Therapy Screening Published in 2024 Listed under Basic Science Download [B11] Pu - Phosphoproteomic Mass Spectrometry Reveals A Novel Therapeutic Target in Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors Published in 2024 Listed under Basic Science Download [B12] Poster - Robledo - Combination of angiogenesis and HIF - 2α blockade: synergistic pair worth exploring in neuroendocrine tumors Published in 2024 Listed under Basic Science, Poster Download [B12] Robledo - Combination of angiogenesis and HIF-2 α blockade: synergistic pair worth exploring in neuroendocrine tumors Published in 2024 Listed under Basic Science Download [B13] Gillis - Transcriptome alterations in pancreatic neuroendocrine tumors among those living with adverse social determinants of health Published in 2024 Listed under Basic Science Download [B14] Chen - Deletion of Notch1 inhibits pancreatic neuroendocrine tumor growth in vivo Published in 2024 Listed under Basic Science Download [B15] Amegble - CDK4/6 and MEK are actionable, therapeutic targets in pancreatic and lung neuroendocrine tumors (NETs) Published in 2024 Listed under Basic Science Download [B16] Mohamed - Comparison of pulmonary versus extra-pulmonary small cell neuroendocrine carcinomas demonstrate distinct genomic alterations Published in 2024 Listed under Basic Science Download [B16] Poster - Mohamed - Comparison of pulmonary versus extra-pulmonary small cell neuroendocrine carcinomas demonstrate distinct genomic alterations Published in 2024 Listed under Basic Science, Poster Download [B17] Mohamed - Molecular landscape of extra-pulmonary small cell neuroendocrine carcinomas based on site of origin Published in 2024 Listed under Basic Science Download [B17] Poster - Mohamed - Molecular landscape of extra-pulmonary small cell neuroendocrine carcinomas based on site of origin Published in 2024 Listed under Basic Science, Poster Download [B18] Mohamed - Uncovering genomic differences between small and large cell extra-pulmonary neuroendocrine carcinomas Published in 2024 Listed under Basic Science Download [B18] Poster - Mohamed - Uncovering genomic differences between small and large cell extra-pulmonary neuroendocrine carcinomas Published in 2024 Listed under Basic Science, Poster Download [B19] Paulson - Activity of nab-Sirolimus Alone or in Combination with Cabozantinib, Octreotide, or Talazoparib in Nonclinical Neuroendocrine Tumor Models Published in 2024 Listed under Basic Science Download [B1] Liu - Development of innovative in vitro and in vivo patient- derived cancer models for translational studies in G1/G2 gastroenteropancreatic neuroendocrine tumors Published in 2024 Listed under Basic Science Download [B1] Poster - Yi - Development of innovative in vitro and in vivo patient-derived cancer models for translational studies in G1/G2 gastroenteropancreatic neuroendocrine tumors Published in 2024 Listed under Basic Science, Poster Download [B20] Poster - Heaphy - Spatial analysis of the tumor microenvironment in pancreatic neuroendocrine tumors Published in 2024 Listed under Basic Science, Poster Download [B20] Xu - Spatial analysis of the tumor microenvironment in pancreatic neuroendocrine tumors Published in 2024 Listed under Basic Science Download [B21] Guo - Therapeutic Targeting of SDHB-Deficient Tumors Published in 2024 Listed under Basic Science Download [B22] Chaoul - TILs from panNET liver metastases: in search of novel adoptive transfer strategies for the treatment of NETs Published in 2024 Listed under Basic Science Download [B22] Poster - Chaoul - TILs from panNET liver metastases: in search of novel adoptive transfer strategies for the treatment of NETs Published in 2024 Listed under Basic Science, Poster Download [B23] Zhao - A Novel Nonpeptide Drug Conjugate (NDC) for the Treatment of Somatostatin Receptor 2-Expressing Tumors Published in 2024 Listed under Basic Science Download [B24] Sundby - Cell-free methylation signatures non-invasively distinguish patients with MEN1 and provide insights into the biology underlying dpNETs Published in 2024 Listed under Basic Science Download [B25] Kidd - NETest® 2.0 – A Decade of Innovation in Neuroendocrine Tumor/Neoplasm Diagnostics Published in 2024 Listed under Basic Science Download [B26] Pu - Leveraging Cell Mass Measurements To Assess Drug Efficacy For Gastroenteropancreatic Neuroendocrine Tumor Liver Metastases And Advanced Adrenocortical Carcinoma Published in 2024 Listed under Basic Science Download [B27] Kulathunga - Use of patient-derived pre-clinical models to identify new and effective treatments for neuroendocrine tumors Published in 2024 Listed under Basic Science Download [B27] Poster - Kulathunga - Use of patient-derived pre-clinical models to identify new and effective treatments for neuroendocrine tumors Published in 2024 Listed under Basic Science, Poster Download [B28] Poster - Skill - Stratification of neuroendocrine tumors for ecto - 5 - nucleotidase expression for clinical trials Published in 2024 Listed under Basic Science, Poster Download [B28] Skill - Stratification of neuroendocrine tumors for ecto-5-nucleotidase expression for clinical trials Published in 2024 Listed under Basic Science Download [B2] Poster - Yogo - Spatial Transcriptomics of Multifocal Ileal Neuroendocrine Tumors Reveals Tumor Heterogeneity based on Tumor Microenvironment and New Biomarkers Published in 2024 Listed under Basic Science, Poster Download [B2] Yogo - Spatial Transcriptomics of Multifocal Ileal Neuroendocrine Tumors Reveals Tumor Heterogeneity based on Tumor Microenvironment and New Biomarkers Published in 2024 Listed under Basic Science Download [B3] Yossef - Investigating the Role of Oncometabolites in von Hippel Lindau disease-related Pancreatic Neuroendocrine Neoplasms Published in 2024 Listed under Basic Science Download [B4] Duan - Hedgehog signaling drives glial cell plasticity and oncogenic reprogramming in gastroenteropancreatic neuroendocrine tumors Published in 2024 Listed under Basic Science Download [B5] Makinen - Single-nucleus transcriptome profiling of enterochromaffin cells in SI-NET patients Published in 2024 Listed under Basic Science Download [B6] Pelle - A novel hormone based anti-SSTR bispecific T-cell engager for the treatment of neuroendocrine tumors Published in 2024 Listed under Basic Science Download [B7] Yellapragada - The Role of Cancer Associated Fibroblasts on the Growth of Pancreatic Neuroendocrine Tumors Published in 2024 Listed under Basic Science Download [B8] Guenter - Surface calreticulin induction by doxorubicin in a patient derived xenograft model of pancreatic neuroendocrine carcinoma Published in 2024 Listed under Basic Science Download [B9] Forsythe - Establishment of a long term gastric neuroendocrine tumor organoid and matched patient derived xenograft Published in 2024 Listed under Basic Science Download [C10] Strosberg - RZ358 (Ersodetug) as a Novel Therapy for Hypoglycemia due to Tumor Hyperinsulinism: Outcomes from an Expanded Access Program for Compassionate Use Published in 2024 Listed under Clinical Download [C11] Pattnaik - Survivin and DLL-3 as predictors of survival in low-grade neuroendocrine tumor patients Published in 2024 Listed under Clinical Download [C12] Capdevila - Updated Phase 1 data for the DLL3/CD3 IgG-like T-cell engager BI 764532 in DLL3-positive tumors: focus on extrapulmonary neuroendocrine carcinomas Published in 2024 Listed under Clinical Download [C13] Mulla - Patterns of long-term remission or apparent cure in a cohort of patients with grade 3 neuroendocrine neoplasms (NENs) Published in 2024 Listed under Clinical Download [C13] Poster - Mulla - Patterns of long-term remission or apparent cure in a cohort of patients with grade 3 neuroendocrine neoplasms (NENs) Published in 2024 Listed under Clinical, Poster Download [C14] Shrestha - Approach Integrating ERCP with Radiofrequency Ablation for Long-term Management for metastatic pancreatic NET to biliary tree as klatskin tumor Published in 2024 Listed under Clinical Download [C15] Poster - Shaheen - RECIST for the real world: Impact of Response Evaluation Criteria in Solid Tumors compared to standard radiology reports on p hys ician decisions and patient satisfaction Published in 2024 Listed under Clinical, Poster Download [C15] Shaheen - RECIST for the real world: Impact of Response Evaluation Criteria in Solid Tumors compared to standard radiology reports on physician decisions and patient satisfaction Published in 2024 Listed under Clinical Download [C16] Strosberg - Targeted Alpha Therapy with 212Pb-DOTAMTATE in subjects with advanced somatostatin receptor-expressing gastroenteropancreatic neuroendocrine tumors Published in 2024 Listed under Clinical Download [C17] Halperin - ACTION-1 phase Ib/3 trial of RYZ101 in gastroenteropancreatic neuroendocrine tumors progressing after 177Lu somatostatin analogue therapy: Phase 1b safety/efficacy Published in 2024 Listed under Clinical Download [C18] del Rivero - DNA Damage Repair Mutational Status’s Effect on Lu-177- DOTATATE in Combination with Olaparib in Metastatic SSTR+ GI Neuroendocrine Tumor: Preliminary Results Published in 2024 Listed under Clinical Download [C19] Moselam - Safety of Lutetium-177 DOTATATE Treatment in Patients with Advanced Neuroendocrine Tumors and Extensive/ Innumerable Bone Metastases Published in 2024 Listed under Clinical Download [C19] Poster - Mosalem - Safety of Lutetium-177 DOTATATE Treatment in Patients with Advanced Neuroendocrine Tumors and Extensive/Innumerable Bone Metastases Published in 2024 Listed under Clinical, Poster Download [C1] Mohamed - NP-101 in Combination with Nivolumab and Ipilimumab in Metastatic Extra-pulmonary Neuroendocrine Carcinomas (EP-NECs): A Pilot Study Published in 2024 Listed under Clinical Download [C1] Poster - Mohamed - NP-101 in Combination with Nivolumab and Ipilimumab in Metastatic Extra-pulmonary Neuroendocrine Carcinomas (EP-NECs): A PIlot Study Published in 2024 Listed under Clinical, Poster Download [C20] Sriwastwa - Imaging, Clinical, and Safety Outcomes in Metastatic Neuroendocrine Tumor Patients Treated with Peptide Receptor Radionuclide Therapy in the Midwestern USA Published in 2024 Listed under Clinical Download [C21] del Rivero - Effect of Absorbed Dose on Toxicity and Tumor Response of Lu-177-DOTATATE With Olaparib in Gastroenteropancreatic Neuroendocrine Patients: Preliminary Results Published in 2024 Listed under Clinical Download [C22] Porfido - Multicenter clinical registry of patients with a neuroendocrine tumor (NET) diagnosis receiving 177Lu-DOTATATE Published in 2024 Listed under Clinical Download [C22] Poster - Porfido - Multicenter clinical registry of patients with a neuroendocrine tumor (NET) diagnosis receiving 177Lu - DOTATATE Published in 2024 Listed under Clinical, Poster Download [C23] Porfido - Neuroendocrine tumor (NET) progression of disease during or within one year after completion of therapy with 177Lu-DOTATATE Published in 2024 Listed under Clinical Download [C23] Poster - Porfido - Neuroendocrine tumor (NET) progression of disease during or within one year after completion of therapy with 177Lu - DOTATATE Published in 2024 Listed under Clinical, Poster Download [C24] Barnett - Evaluating Time to Treatment Start for Patients Receiving Peptide Receptor Radioligand Therapy Published in 2024 Listed under Clinical Download [C25] O'Leary - Does Liver Tumor Morphology Predict Outcomes after LDT, PRRT or CapTem? Published in 2024 Listed under Clinical Download [C25] Poster - O'Leary - Associations between patterns of neuroendocrine liver metastatic burden and outcomes after embolization, CapTem and PRRT Published in 2024 Listed under Clinical, Poster Download [C26] Meredith - Incidence and Characterization of Carcinoid Crises post Embolization of Neuroendocrine Tumor Liver Metastases Published in 2024 Listed under Clinical Download [C27] Fidelman - A Pilot Study of Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Well-Differentiated Neuroendocrine Tumors and Symptomatic and/or Progressive Metastases Published in 2024 Listed under Clinical Download [C27] Poster - Fidelman - A Pilot Study of Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Grade 2/3 Well - Differentiated Neuroendocrine Tumors Published in 2024 Listed under Clinical, Poster Download [C28] Poster - Zhou - Liver - directed therapy for metastatic neuroendocrine carcinoma and grade 3 well - differentiated neuroendocrine tumors Published in 2024 Listed under Clinical, Poster Download [C28] Zhou - Liver-directed therapy for metastatic neuroendocrine carcinoma and grade 3 well-differentiated neuroendocrine tumors Published in 2024 Listed under Clinical Download [C29] D'Souza - Initial Outcomes of Integrating Yttrium-90 Radioembolization with Capecitabine-Temozolomide for Grade 3 Liver-Dominant Metastatic Neuroendocrine Tumors Published in 2024 Listed under Clinical Download [C29] Poster - D'Souza - Integrating Yttrium - 90 Radioembolization with Capecitabine - Temozolomide for Grade 3 Liver - Dominant Metastatic Neuroendocrine Tumors: Initial Outcomes Published in 2024 Listed under Clinical, Poster Download [C2] Sun - Preliminary clinical activity of surufatinib combined with octreotide LAR in patients with G1/2 gastroenteropancreatic neuroendocrine tumor (GEP-NET) Published in 2024 Listed under Clinical Download [C30] Maratta - Somatostatin receptor expression of gastroenteropancreatic neuroendocrine tumors: A comprehensive analysis of expression in the era of somatostatin receptor PET imaging Published in 2024 Listed under Clinical Download [C31] Singh - First-Line Efficacy of [177Lu]Lu-DOTA-TATE in Gastroenteropancreatic Neuroendocrine Tumors by Tumor Grade and Primary Origin: Phase 3 NETTER-2 Subgroup Analysis Published in 2024 Listed under Clinical Download [C32] Bilgin - Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE in Patients with Malignant Pheochromocytoma (PCC) and Paraganglioma (PGL): A Single Institution Retrospective Study Published in 2024 Listed under Clinical Download [C33] Cass - Corticosteroid prophylaxis did not decrease tumor flare reaction in high-risk neuroendocrine tumors patients treated with 177Lu-DOTATATE Published in 2024 Listed under Clinical Download [C34] Poster - Tuchayi - Peptide Receptor Radionuclide Therapy with 177 Lu - DOTATATE: A Single Center Experience Published in 2024 Listed under Clinical, Poster Download [C34] Tuchayi - Peptide Receptor Radionuclide Therapy with 177 Lu- DOTATATE: A Single Center Experience Published in 2024 Listed under Clinical Download [C35] Jacques - Small bowel obstruction incidence in Lu177 PRRT patients had no impact on overall survival Published in 2024 Listed under Clinical Download [C35] Poster - Jacques - Small bowel obstruction incidence in Lu177 PRRT patients had no impact on overall survival Published in 2024 Listed under Clinical, Poster Download [C36] Patel - Safety and Efficacy of Peptide Receptor Radionuclide Therapy in Thymic Neuroendocrine Neoplasms: A Single-Institutional Case Series Published in 2024 Listed under Clinical Download [C37] Wahl - Preliminary safety and efficacy data of [212Pb]VMT- α -NET in somatostatin receptor 2 (SSTR2) expressing neuroendocrine tumors (NETs) Published in 2024 Listed under Clinical Download [C38] Poster - Schnell - Radioactivity in drained body cavity fluid following peptide receptor radionuclide therapy with 177Lu DOTATATE in patients with advanced neuroendocrine tumors Published in 2024 Listed under Clinical, Poster Download [C38] Schnell - Radioactivity in drained body cavity fluid following peptide receptor radionuclide therapy with 177Lu DOTATATE in patients with advanced neuroendocrine tumors Published in 2024 Listed under Clinical Download [C39] Winters - Dosimetry-guided 131I-mIBG Therapy in a Hemodialysis- Dependent Paraganglioma Patient Published in 2024 Listed under Clinical Download [C3] Uberroth - Prolonged Response to Dabrafenib/Trametinib in Metastatic Well-Differentiated Grade 3 Pancreatic Neuroendocrine Tumor (NET G3) with BRAF V600E Mutation Published in 2024 Listed under Clinical Download [C40] Winters - Implementation of dosimetry in clinical Lu177-DOTATATE therapy Published in 2024 Listed under Clinical Download [C41] Poster - Yogo - Long-term Survival Outcomes After Minimally Invasive Surgery for Ileal Neuroendocrine Tumors Published in 2024 Listed under Clinical, Poster Download [C41] Yogo - Long-term Survival Outcomes After Minimally Invasive Surgery for Ileal Neuroendocrine Tumors Published in 2024 Listed under Clinical Download [C42] Evans - Loss of MGMT protein expression by immunohistochemistry is associated with response to capecitabine/temozolomide in neuroendocrine neoplasms (NENs) Published in 2024 Listed under Clinical Download [C42] Poster - Evans - Loss of MGMT Protein Expression by Immunohistochemistry is Associated with Response to Capecitabine/Temozolomide in Neuroendocrine Neoplasms (NENs) Published in 2024 Listed under Clinical, Poster Download [C43] Poster - Wornow - To Treat or Not to Treat: Resection of Primary Pancreatic Neuroendocrine Tumors in the Metastatic Setting Published in 2024 Listed under Clinical, Poster Download [C43] Wornow - To Treat or Not to Treat: Resection of Primary Pancreatic Neuroendocrine Tumors in the Metastatic Setting Published in 2024 Listed under Clinical Download [C44] Shi - Incidence and prognostic analysis of neuroendocrine differentiation in CRC, GC, ESCC and BTC cohorts Published in 2024 Listed under Clinical Download [C45] Nkie - Interaction Between Race and Insurance Coverage for Gastroenteropancreatic Neuroendocrine Tumor Outcomes Published in 2024 Listed under Clinical Download [C45] Poster - Nkie - Interaction Between Race and Insurance Coverage for Gastroenteropancreatic Neuroendocrine Tumor Outcomes Published in 2024 Listed under Clinical, Poster Download [C46] Dumitra - Clinical utility of preoperative DOTATATE-PET in small bowel neuroendocrine tumors Published in 2024 Listed under Clinical Download [C47] Poster - Slaby - Response After Neoadjuvant Therapy for Pancreatic Neuroendocrine Tumors Published in 2024 Listed under Clinical, Poster Download [C47] Slaby - Response After Neoadjuvant Therapy for Pancreatic Neuroendocrine Tumors Published in 2024 Listed under Clinical Download [C48] Collier - Impact of Hospital Type and Location on Survival Outcomes for Patients with Well-Differentiated G1/G2 Pancreatic Neuroendocrine Tumors Published in 2024 Listed under Clinical Download [C48] Poster - Collier - Impact of Hospital Type and Location on Survival Outcomes for Patients with Well - Differentiated Pancreatic Neuroendocrine Tumors Published in 2024 Listed under Clinical, Poster Download Select the number of documents per page 5 10 15 20 25 30 50 100 12»
